{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,11,15]],"date-time":"2024-11-15T05:44:20Z","timestamp":1731649460626,"version":"3.28.0"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,11,14]]},"DOI":"10.7759\/cureus.73711","type":"journal-article","created":{"date-parts":[[2024,11,15]],"date-time":"2024-11-15T00:22:39Z","timestamp":1731630159000},"source":"Crossref","is-referenced-by-count":0,"title":["Calcific Uremic Arteriolopathy (CUA) Among Malaysian Dialysis Patients: Clinical Characteristics, Treatment, and Outcome"],"prefix":"10.7759","author":[{"given":"Yee Wan","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min Hui","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sunita","family":"Bavanandan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Boon Cheak","family":"Bee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher Thiam Seong","family":"Lim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rozita","family":"Mohd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yew Foong","family":"Liew","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chek Loong","family":"Loh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen Jiun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fariz Safhan","family":"Mohamad Nor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zaiha","family":"Harun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Korina","family":"Rahmat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clare Hui Hong","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koh Wei","family":"Wong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soo Kun","family":"Lim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1505292","article-title":"Calciphylaxis","volume":"378","author":"Nigwekar SU","year":"2018","unstructured":"Nigwekar SU, Thadhani R, Brandenburg VM. Calciphylaxis. N Engl J Med. 2018, 378:1704-14. 10.1056\/NEJMra1505292","journal-title":"N Engl J Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2015091065","article-title":"A nationally representative study of calcific uremic arteriolopathy risk factors","volume":"27","author":"Nigwekar SU","year":"2016","unstructured":"Nigwekar SU, Zhao S, Wenger J, Hymes JL, Maddux FW, Thadhani RI, Chan KE. A nationally representative study of calcific uremic arteriolopathy risk factors. J Am Soc Nephrol. 2016, 27:3421-9. 10.1681\/ASN.2015091065","journal-title":"J Am Soc Nephrol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfv438","article-title":"Calcific uraemic arteriolopathy (calciphylaxis): data from a large nationwide registry","volume":"32","author":"Brandenburg VM","year":"2017","unstructured":"Brandenburg VM, Kramann R, Rothe H, et al.. Calcific uraemic arteriolopathy (calciphylaxis): data from a large nationwide registry. Nephrol Dial Transplant. 2017, 32:126-32. 10.1093\/ndt\/gfv438","journal-title":"Nephrol Dial Transplant"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s10157-013-0782-z","article-title":"Calciphylaxis: diagnosis and clinical features","volume":"17","author":"Hayashi M","year":"2013","unstructured":"Hayashi M. Calciphylaxis: diagnosis and clinical features. Clin Exp Nephrol. 2013, 17:498-503. 10.1007\/s10157-013-0782-z","journal-title":"Clin Exp Nephrol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/s0039-6060(97)90212-9","article-title":"Calciphylaxis in patients on hemodialysis: a prevalence study","volume":"122","author":"Angelis M","year":"1997","unstructured":"Angelis M, Wong LL, Myers SA, Wong LM. Calciphylaxis in patients on hemodialysis: a prevalence study. Surgery. 1997, 122:1083-9. 10.1016\/s0039-6060(97)90212-9","journal-title":"Surgery"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1186\/s12882-020-01722-y","article-title":"Calciphylaxis epidemiology, risk factors, treatment and survival among French chronic kidney disease patients: a case-control study","volume":"21","author":"Gaisne R","year":"2020","unstructured":"Gaisne R, P\u00e9r\u00e9 M, Menoyo V, Hourmant M, Larmet-Burgeot D. Calciphylaxis epidemiology, risk factors, treatment and survival among French chronic kidney disease patients: a case-control study. BMC Nephrol. 2020, 21:63. 10.1186\/s12882-020-01722-y","journal-title":"BMC Nephrol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2016.06.025","article-title":"Survival, risk factors, and effect of treatment in 101 patients with calciphylaxis","volume":"91","author":"McCarthy JT","year":"2016","unstructured":"McCarthy JT, El-Azhary RA, Patzelt MT, et al.. Survival, risk factors, and effect of treatment in 101 patients with calciphylaxis. Mayo Clin Proc. 2016, 91:1384-94. 10.1016\/j.mayocp.2016.06.025","journal-title":"Mayo Clin Proc"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2002.00375.x","article-title":"Calciphylaxis is usually non-ulcerating: risk factors, outcome and therapy","volume":"61","author":"Fine A","year":"2002","unstructured":"Fine A, Zacharias J. Calciphylaxis is usually non-ulcerating: risk factors, outcome and therapy. Kidney Int. 2002, 61:2210-7. 10.1046\/j.1523-1755.2002.00375.x","journal-title":"Kidney Int"},{"key":"ref9","unstructured":"Concise summary of essential statistics for year 2020. (2022). https.\/\/msn.org.my\/nrr\/wp-content\/uploads\/2022\/12\/Concise-Summary-of-Essential-Statistics-for-year-2020-dated-19th-Oc...."},{"key":"ref10","doi-asserted-by":"crossref","DOI":"10.2215\/CJN.00530108","article-title":"Calciphylaxis from nonuremic causes: a systematic review","volume":"3","author":"Nigwekar SU","year":"2008","unstructured":"Nigwekar SU, Wolf M, Sterns RH, Hix JK. Calciphylaxis from nonuremic causes: a systematic review. Clin J Am Soc Nephrol. 2008, 3:1139-43.","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref11","article-title":"Calcific uremic arteriolopathy in peritoneal dialysis populations","volume":"2011","author":"New N","year":"2011","unstructured":"New N, Mohandas J, John GT, Ratanjee S, Healy H, Francis L, Ranganathan D. Calcific uremic arteriolopathy in peritoneal dialysis populations. Int J Nephrol. 2011, 2011:982854.","journal-title":"Int J Nephrol"},{"key":"ref12","article-title":"National Health and Morbidity Survey (NHMS) 2023: Non-communicable Diseases and Healthcare Demand - Key Findings","author":"Institute for Public Health 2024","year":"2024","unstructured":"Institute for Public Health 2024. National Health and Morbidity Survey (NHMS) 2023: Non-communicable Diseases and Healthcare Demand-Key Findings. Institute for Public Health National Institutes of Health (NIH) Ministry of Health Malaysia, Selangor; 2024. https:\/\/iku.nih.gov.my\/images\/nhms2023\/key-findings-nhms-2023.pdf."},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2004.03.018","article-title":"Successful treatment of calciphylaxis with intravenous sodium thiosulfate","volume":"43","author":"Cicone JS","year":"2004","unstructured":"Cicone JS, Petronis JB, Embert CD, Spector DA. Successful treatment of calciphylaxis with intravenous sodium thiosulfate. Am J Kidney Dis. 2004, 43:1104-8. 10.1053\/j.ajkd.2004.03.018","journal-title":"Am J Kidney Dis"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1111\/nep.13666","article-title":"Rheopheresis: a new therapeutic approach in severe calciphylaxis","volume":"25","author":"Robert T","year":"2020","unstructured":"Robert T, Lionet A, Bataille S, Seret G. Rheopheresis: a new therapeutic approach in severe calciphylaxis. Nephrology (Carlton). 2020, 25:298-304. 10.1111\/nep.13666","journal-title":"Nephrology (Carlton)"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/289751-calcific-uremic-arteriolopathy-cua-among-malaysian-dialysis-patients-clinical-characteristics-treatment-and-outcome","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,15]],"date-time":"2024-11-15T00:22:42Z","timestamp":1731630162000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/289751-calcific-uremic-arteriolopathy-cua-among-malaysian-dialysis-patients-clinical-characteristics-treatment-and-outcome"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,14]]},"references-count":14,"URL":"https:\/\/doi.org\/10.7759\/cureus.73711","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11,14]]}}}